Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Forum
  • Discovery
  • About Us
    • Our Coverage
    • Team

Dicot Pharma

0.39 SEK

-1.28 %

Less than 1K followers

DICOT

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Dicot Pharma

Q3/24Q4/242024Q1/25Q2/25Q3/25Q4/252025
Revenue
EBITDA-10.4-21.7-59.3-23.6-25.0-16.6-17.2-82.4
EBIT-10.4-21.7-59.3-23.6-24.9-16.6-17.2-82.4
EBIT-%
Profit before taxes-10.2-21.7-57.7-22.9-24.3-16.1-16.8-80.2
Net income-10.2-20.8-57.7-22.9-24.3-16.1-16.8-80.2
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.